Fatima Eltyeb Hago: Are We Doing More Harm Than Good with Combination Antithrombotic Therapy in AF?
Fatima Eltyeb Hago, Clinical Pharmacist at Dr. Sulaiman AL Habib Medical Group, shared on LinkedIn:
”Are we doing more harm than good with combination antithrombotic therapy in our AF patients?
In anticoagulated patients with atrial fibrillation, antiplatelet therapy should be the exception not the rule.
41% reduction in major bleeding with OAC alone vs. combination therapy .
(Gargiulo et al., JACC 2026 – meta-analysis of 4 RCTs, 4,092 patients)
45% of APT users in post-acute long-term care settings have no clear indication .
(Ko et al., JAMA Internal Medicine 2024)
Yet aspirin and P2Y12 inhibitors continue to be prescribed alongside anticoagulation with no reassessment, no stop dates, and no clear rationale.
This 2026 guide from the Anticoagulation Forum gives us the framework to act , verify the indication, assess the timing, and make a clear clinical decision: (deprescribe, monitor, or continue) with a defined plan.”
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 21, 2026, 04:06Allison Lewin: How Gender Shapes the Way We Receive Medical Care
-
Sep 21, 2026, 03:49Jessica Lee: Walking Together for a Stronger Bleeding Disorders Community
-
Sep 21, 2026, 03:36Syed Asif Ali Shah: From Pakistan to Australia – A Clinical Haematology Milestone
-
Sep 21, 2026, 03:22Katie Baca-Motes: Estradiol Fluctuations May Help Explain Menstrual Migraine
-
Sep 21, 2026, 03:00Family History Can Reveal Hidden Risk of Aortic Dissection – The Marfan Foundation
-
Sep 21, 2026, 02:47Transitioning from Paediatric to Adult Haemophilia Care – Haemophilia Foundation Australia
-
Sep 21, 2026, 02:29Diana Castro Paupério: A New Era for Patient Blood Management
-
Sep 21, 2026, 00:29Iheanyichukwu Ike: Childhood Anaemia in Nigeria Through an Analysis of the 2018 NDHS
-
Sep 21, 2026, 00:27Nicole De Vita: The Global Burden of Iron Deficiency and Anemia in Women at SABM